These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1345967)

  • 1. Eradicating Helicobacter pylori.
    Bell GD; Powell K
    Lancet; 1992 Jan; 339(8784):55. PubMed ID: 1345967
    [No Abstract]   [Full Text] [Related]  

  • 2. Eradicating Helicobacter pylori.
    Katelaris P
    Lancet; 1992 Jan; 339(8784):54. PubMed ID: 1345965
    [No Abstract]   [Full Text] [Related]  

  • 3. Eradicating Helicobacter pylori.
    Glupczynski Y; Burette A
    Lancet; 1992 Jan; 339(8784):54-5. PubMed ID: 1345966
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradicating Helicobacter pylori.
    Rautelin H; Kosunen TU; Seppälä K
    Lancet; 1992 Jan; 339(8784):55. PubMed ID: 1345968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
    Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
    Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication and reinfection.
    Bell GD; Powell KU
    Lancet; 1995 Jun; 345(8965):1646; author reply 1647-8. PubMed ID: 7632295
    [No Abstract]   [Full Text] [Related]  

  • 9. How effective are quadruple therapies as first-line H. pylori eradication therapies?
    Borody TJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):174-5. PubMed ID: 16265179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative?].
    Zala G; Wirth HP; Bauer S; Wüst J; Flury R; Meyenberger C; Ammann R
    Schweiz Med Wochenschr; 1994 Aug; 124(31-32):1385-90. PubMed ID: 8091166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
    Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
    Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
    Graham DY; Lee SY
    Gastroenterol Clin North Am; 2015 Sep; 44(3):537-63. PubMed ID: 26314667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 15. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The who's and when's of therapy for Helicobacter pylori.
    Graham DY; Börsch GM
    Am J Gastroenterol; 1990 Dec; 85(12):1552-5. PubMed ID: 2252013
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection.
    Venerito M; Krieger T; Ecker T; Leandro G; Malfertheiner P
    Digestion; 2013; 88(1):33-45. PubMed ID: 23880479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
    Gungor G; Baglıcakoglu M; Kayacetin E; Biyik M; Ucar R; Goktepe H; Ataseven H; Demir A
    Digestion; 2015; 92(2):55-9. PubMed ID: 26183105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.